-The Economic Times Prime minister Manmohan Singh is meeting a group of ministers including Finance Minister Pranab Mukherjee, Agriculture Minister Sharad Pawar, Food Minister KV Thomas and Commerce Minister Anand Sharma to arrive at a consensus on trade policies especially in sugar and cotton exports. Recently, Pawar had criticized the export policies of cotton and sugar. The sugar export is a contentious issue as even after having a surplus production and international...

-The Economic Times India will have a normal monsoon this year, says the Met office. This is good news, even though the forecast does not rule out some slack during the second half of the season. What matters finally is the distribution of rainfall across space and time rather than the aggregate percentages. However, a good monsoon is only one side of the story to have a strong farm sector. Reforms are...

The Chhattisgarh government does not yet know if the recorded message from Maoists on using their hostage Alex Paul Menon, a young bureaucrat, as a bargaining chip to get eight of their jailed comrades released, is authentic or not. A Maoist gang abducted Menon, a 32-year-old IAS officer of batch 2006, on Saturday evening at gunpoint from Manjhipara in Sukma, where he is the district collector, killing two guards who resisted...

NEW DELHI: It could be a second innings for special economic zones, especially those held up for years, with the commerce department proposing fresh tax concessions and a cut in the minimum area requirement to a quarter of the present specifications. The department has suggested that any zone that is not built around the identified 40 million-plus cities and state capitals would be eligible for duty benefits on capital investment for...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...